The Stanford Biodesign Innovation Program, in cooperation with Windhover Information, Wilson Sonsini Goodrich & Rosati and PricewaterhouseCoopers, presents a unique opportunity to hear Dr. Richard S. Stack, interviewed by David Cassak, Managing Partner, Windhover Information.
Richard S. Stack is Managing General Partner of SyneCor, LLC, a business generator of new Life Sciences companies based in the Research Triangle Park, North Carolina, and Menlo Park, California. SyneCor has significant academic, scientific, physician, venture capital, corporate, and investment banking partnerships and is focusing its efforts on the identification and development of proprietary, transformational technologies with extraordinary market potential in the cardiovascular disease field.
Dr. Stack is currently the Executive Director of ACRI (the Atlanta Cardiovascular Research Institute) and is a Professor of Medicine in Cardiology on leave of absence from Duke University Medical Center in Durham, North Carolina. Dr. Stack completed his fellowship training in Cardiology at Duke University in 1982.
Dr. Stack's academic appointments have been served at Duke University Medical Center, beginning as an Associate in Medicine, Cardiology (1982-1983). Dr. Stack became an Assistant Professor of Medicine, Cardiology (1983-1989), and Associate Professor of Medicine, Cardiology (1989-1997), and is currently Professor of Medicine (Tenured - on leave of absence), Cardiology (1997 - present).
Dr. Stack has authored well over 330 manuscripts, book chapters, and abstracts. Dr. Stack has been a Principal and Co-principal Investigator for three NIH grants, has received multiple research awards during his career including International Award for Best Experimental Research (1995 - Thoraxcenter, Netherlands) and is listed in Who's Who in Cardiology.
Dr. Stack is also an inventor of several devices that are designed to improve and further the technology of angioplasty. Dr. Stack holds twelve current worldwide patents and has an additional eight patents pending on a variety of vascular and therapeutic devices. Currently, Dr. Stack's research team is developing a drug delivery stent device, invented by Dr. Stack, which holds great promise for overcoming many of the limitations of current stents. A major thrust of Dr. Stack's current basic and clinical research effort includes new devices for the treatment of peripheral vascular disease, particularly cerebrovascular disease.